Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30
$2.55−0.21 (-7.61%)
Close on Nov 18, 2026Market cap $104.71MP/E –Yield –
Scienture operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Scienture's operating cash flow for the twelve months ending Jun 30, 2026 was -$14.44M. For fiscal 2025 it was -$13.38M. The highest annual figure on record is $273.39K in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.38M | – |
| FY2024 | Dec 31, 2024 | -$14.27M | – |
| FY2023 | Dec 31, 2023 | -$2.23M | – |
| FY2022 | Dec 31, 2022 | -$199.02K | – |
| FY2021 | Dec 31, 2021 | -$2.57M | – |
| FY2020 | Dec 31, 2020 | -$2.21M | -1662.2% |
| FY2019 | Dec 31, 2019 | $141.78K | -48.1% |
| FY2018 | Dec 31, 2018 | $273.39K | +59.3% |
| FY2017 | Dec 31, 2017 | $171.67K | – |
| FY2016 | Dec 31, 2016 | -$503.53K | -657.1% |
| FY2015 | Dec 31, 2015 | $90.39K | – |
| FY2014 | Dec 31, 2014 | -$1.06M | – |
| FY2013 | Dec 31, 2013 | -$844.58K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.13M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.92M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.18M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.21M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.03M | -148.2% |
| Q1 FY2025 | Mar 31, 2025 | -$2.96M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.91M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.39M | – |
| Q2 FY2024 | Jun 30, 2024 | $4.22M | +1185.0% |
| Q1 FY2024 | Mar 31, 2024 | -$10.19M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.02M | -139.9% |
| Q3 FY2023 | Sep 30, 2023 | -$603.11K | – |
| Q2 FY2023 | Jun 30, 2023 | $328.57K | – |
| Q1 FY2023 | Mar 31, 2023 | -$931.53K | – |
| Q4 FY2022 | Dec 31, 2022 | $2.56M | – |
| Q3 FY2022 | Sep 30, 2022 | -$576.93K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.18M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.00M | – |
| Q4 FY2021 | Dec 31, 2021 | -$426.72K | – |
| Q3 FY2021 | Sep 30, 2021 | -$738.10K | -129.7% |
| Q2 FY2021 | Jun 30, 2021 | -$691.12K | – |
| Q1 FY2021 | Mar 31, 2021 | -$710.30K | – |
| Q4 FY2020 | Dec 31, 2020 | -$715.54K | – |
| Q3 FY2020 | Sep 30, 2020 | $2.48M | +514.3% |
| Q2 FY2020 | Jun 30, 2020 | -$3.57M | -7847.2% |
| Q1 FY2020 | Mar 31, 2020 | -$410.81K | – |
| Q4 FY2019 | Dec 31, 2019 | -$182.79K | -534.5% |
| Q3 FY2019 | Sep 30, 2019 | $404.25K | +376.4% |
| Q2 FY2019 | Jun 30, 2019 | $46.11K | -42.2% |
| Q1 FY2019 | Mar 31, 2019 | -$125.79K | -288.7% |
| Q4 FY2018 | Dec 31, 2018 | $42.07K | -21.1% |
| Q3 FY2018 | Sep 30, 2018 | $84.86K | -27.3% |
| Q2 FY2018 | Jun 30, 2018 | $79.79K | +60.0% |
| Q1 FY2018 | Mar 31, 2018 | $66.66K | – |
| Q4 FY2017 | Dec 31, 2017 | $53.32K | – |
| Q3 FY2017 | Sep 30, 2017 | $116.78K | – |
| Q2 FY2017 | Jun 30, 2017 | $49.86K | – |
| Q1 FY2017 | Mar 31, 2017 | -$48.28K | – |
| Q4 FY2016 | Dec 31, 2016 | -$226.87K | – |
| Q3 FY2016 | Sep 30, 2016 | -$31.50K | – |
See a number that looks wrong?